Penn Medicine’s Gary Lichtenstein, professor of medicine, and Gary Wu, the Ferdinand G. Weisbrod Professor in Gastroenterology, received 2015 Inflammatory Bowel Disease (IBD) Scientific Achievement Awards from the Crohn’s & Colitis Foundation of America (CCFA). The awards were given at the CCFA’s annual Advances in Inflammatory Bowel Diseases Conference in Orlando, Florida in December.

Dr. Lichtenstein was awarded the Scientific Achievement in IBD Clinical Research Award. He has led Penn’s Inflammatory Bowel Disease Center for 22 years. He currently researches investigational therapies for ulcerative colitis (UC) and Crohn’s disease treatments. He has served as the principal investigator in trials evaluating novel agents in the treatment of UC and Crohn’s disease.

Dr. Wu won the Scientific Achievement in Basic IBD Research Award. He serves as associate chief for research in gastroenterology, co-director of the Penn-CHOP Microbiome Program and associate director of Penn’s Center for Molecular Studies in Digestive and Liver Disease. He is also an elected member of the American Society for Clinical Investigation and the Association of American Physicians.